vTv Therapeutics Inc. (VTVT) financial statements and ratios from SEC XBRL: revenue $0.00 (TTM), revenue growth -100.0% YoY, P/E 119.9. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $0.00 |
| Return on Equity | 2.5% |
| Current Ratio | 14.36 |
| Revenue Growth (YoY) | -100.0% |
| P/E Ratio | 119.9 |
| EV / EBITDA | -56.7 |
| Price / Book | 3.00 |
| Price / Sales | 7.33 |
| FCF Yield | -3.9% |
| Altman Z-Score | 1.18 (distress) |
| Sector P/E (Healthcare) | 21.7 |
VTVT overview · VTVT earnings · VTVT KPIs · VTVT investor relations · VTVT ownership · VTVT peers · VTVT filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.